Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Retrotransposon Gag-like protein 10 (RTL10) is a protein-coding gene in humans originally derived from long terminal repeat (LTR) retrotransposon Gag sequences[2]. It is a member of the retrotransposon Gag-like (RTL/SIRH) family, which consists of domesticated retrotransposon or retroviral gene products[2]. RTL10 participates in mitochondrial outer membrane permeabilization and the regulation of mitochondrial membrane potential, important processes in the intrinsic apoptotic pathway[1]. The protein may induce apoptosis through its BH3 domain, possibly interacting with members of the Bcl-2 family to modulate apoptotic signaling[1]. RTL10 is localized to the mitochondria[1]. Disease associations include autoimmune lymphoproliferative syndrome and certain leukemias based on gene variant and expression data, but it is not widely regarded as a direct therapeutic target and there are no drugs in clinical use or development targeting RTL10[1][2].
Not applicable; no drugs are reported to target this molecule. The protein itself may induce apoptosis through a BH3-domain-dependent mechanism, potentially by interacting with Bcl-2 family members at the mitochondrial membrane
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Retrotransposon Gag-like protein 10 (RTL10).